This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Laboratory Corp of America Hldgs (LH)

NYSE: Health Care

11/27/15 - 1:01:00 PM ET
  • Prev Close: 121.82
  • Avg Vol: 1.09M
  • Shares Outstanding: 101.20M
  • Mkt Cap: 12.33B
  • Div: --
  • Div Yield: --
  • P/E: 26.37
  • EPS: 6.03
LH Day's Range
LH 52 Week Range
LH Business Summary
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide.View LH key stats
Laboratory Corp of America Hldgs - LH - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Laboratory Corp of America Hldgs as a Buy with a ratings score of A-.
Report Snippet: We rate LABORATORY CP OF AMER HLDGS (LH) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, good cash flow from operations, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.
Rating: 4.33 out of 5, 'A-' Buy.
You can view the full analysis from the report here:
LH Rating Report
LH Earnings Transcripts
  • Laboratory Corps Of America Hldings (LH) Earnings Report: Q3 2015 Conference Call Transcript
    TheStreet | 10/26/15 - 12:28 PM EDT
  • Laboratory Corp Of America (LH) Earnings Report: Q2 2015 Conference Call Transcript
    TheStreet | 07/28/15 - 05:39 PM EDT
  • Laboratory Corp Of America (LH) Earnings Report: Q1 2015 Conference Call Transcript
    TheStreet | 04/27/15 - 01:29 PM EDT
  • Laboratory Corporation Of America Holdings (LH) Earnings Report: Q4 2014 Conference Call Transcript
    TheStreet | 02/20/15 - 10:27 PM EST
LH Performance as of Prev. Close
LH EPS Performance
1-Yr Ago
2-Yrs Ago
3-Yrs Ago
LH Percentage in these ETFs
LH News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

LH Laboratory Corp of America Hldgs

Chart of LH

Analysts Ratings for LH

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 11 11 11
Moderate Buy 2 2 2 2
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

LH Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs